School of Medicine

The Latest

Protein That Protects During Stress Sheds Light on How Diabetes Drug Prevents Tumors

Researchers at University of California San Diego School of Medicine have identified a previously unknown mechanism that helps fortify the structure and tight junctions between epithelial cells — a basic cell type that lines various body cavities and organs throughout the body, forming a protective barrier against toxins, pathogens and inflammatory triggers. Breaches of this barrier can provoke organ dysfunction and development of tumors.

In Third ‘Inside Innovation’ Talk, Experts Update Research into Strokes

The next presentation in UC San Diego’s “Inside Innovation” series features professors Andrew Kahn and Juan C. del Alamo discussing their latest research into quantifying a person’s risk for stroke through analyzing blood flow through the heart.

Older First-Time Mothers Are Also More Likely to Live Longer

The average age of a woman giving birth for the first time has risen dramatically in the United States over the past 40 years, driven by factors like education or career. A new study by researchers at University of California San Diego School of Medicine found that women choosing to become first-time mothers later in life may increase their chances of living into their 90s.

UC San Diego Health to Open Jacobs Medical Center November 20, 2016

UC San Diego Health will open Jacobs Medical Center, a 245-bed medical and surgical specialty hospital, on November 20, 2016. Named in recognition of $100 million in gifts from Joan and Irwin Jacobs, the 10-story facility combines renowned physician-scientists and care teams, precision medicine, clinical trials and creative arts and culinary offerings to provide an extraordinary healing experience for patients and families.

Study Finds Psoriasis Drug Significantly Effective in Treating Crohn’s Disease

Researchers at University of California San Diego School of Medicine have shown that ustekinumab, a human antibody used to treat arthritis, significantly induces response and remission in patients with moderate to severe Crohn’s disease. Results of the clinical trial will appear in the November 16 issue of the New England Journal of Medicine.

New Bioinformatic Analysis Reveals Role of Proteins in Diabetic Kidney Disease

A new bioinformatic framework developed by researchers at University of California San Diego School of Medicine has identified key proteins significantly altered at the gene-expression level in biopsied tissue from patients with diabetic kidney disease, a result that may reveal new therapeutic targets.